Phospho-NCF4 (T154) Antibody

Basic Experimental Design

Q1: What are the validated applications for Phospho-NCF4 (T154) antibodies, and how should they be optimized?

Phospho-NCF4 (T154) antibodies are primarily validated for Western blot (WB) and ELISA, with additional use in immunohistochemistry (IHC) and immunofluorescence (IF) for specific vendors . For WB:

• Dilution: 1:500–1:1000 (e.g., Boster P04208, Abclonal AP1193) .

• Positive controls: PMA/TPA-treated Jurkat cells (induces NCF4 phosphorylation) .

• Sample preparation: Lysate from myeloid-derived cells (e.g., THP-1, K562) .

For IHC:

• Dilution: 1:100–1:300 .

• Fixation: Paraffin-embedded sections (e.g., human ovary or breast carcinoma tissue) .

Table 1: Antibody Specifications Across Vendors

Antibody Specificity and Validation

Q2: How should I validate Phospho-NCF4 (T154) antibody specificity in a novel experimental model?

• Phosphopeptide blocking: Use the phosphorylated immunogen peptide to compete with antibody binding. A loss of signal confirms specificity .

• Phosphatase treatment: Incubate lysates with λ-phosphatase to dephosphorylate NCF4. Absence of WB signal at ~40 kDa confirms phospho-specificity .

• Mutational analysis: Compare WT NCF4 vs. T154A mutant in transduced cells (e.g., Ncf4 BMDMs with reconstituted WT or T154A NCF4) .

Q3: How does phosphorylation at T154 regulate NCF4 function, and what experimental approaches can elucidate this?

Phosphorylation at T154 negatively regulates NCF4’s interaction with NOX2, reducing NADPH oxidase activity . To study this:

• Co-IP assays: Pull down NCF4 from lysates and assess NOX2 binding. Phosphorylated NCF4 (T154) should show reduced NOX2 association .

• ROS measurement: Compare superoxide production in WT vs. T154A NCF4-expressing cells using DHE or L-012 assays .

• Inflammasome activation: Test NLRP3/ASC complex formation via co-IP or proximity ligation assays (PLA). Phospho-T154 NCF4 may compete for ASC binding .

Key Finding: In Ncf4 BMDMs, T154A mutation prevents NCF4 relocalization to inflammasomes, impairing caspase-1 activation .

Troubleshooting Common Issues

Q4: Why might I observe no signal in Western blot when using Phospho-NCF4 (T154) antibodies, and how can I resolve this?

Cross-Reactivity and Species Considerations

Q5: How does cross-reactivity between human and mouse models affect experimental interpretation?

• Ortholog validation: Confirm T154 conservation between species (e.g., human NCF4 T154 vs. mouse Ncf4 T154).

• Parallel controls: Use human and mouse lysates side-by-side in WB to compare signal intensity.

• Mutational models: Use Ncf4 KO mice reconstituted with WT or T154A NCF4 to isolate phosphorylation effects .

Integrating NCF4 with Inflammasome Pathways

Q6: How can Phospho-NCF4 (T154) antibodies be used to study inflammasome regulation in disease models?

NCF4 phosphorylation at T154 modulates inflammasome activation by competing with ASC for binding to NOX2 . Experimental approaches:

• PKC inhibition: Treat cells with PKC412 (midostaurin) to block NCF4 phosphorylation and assess IL-1β/IL-18 release .

• Single-cell RNA-seq: Profile immune cell subsets (e.g., NK, CD8+ T cells) in Ncf4 vs. WT mice to link NCF4 phosphorylation to immune surveillance .

• In vivo models: Use AOM-DSS-induced colorectal cancer in Ncf4 mice to study tumor progression and IL-18 dependency .

Critical Insight: NCF4 T154 phosphorylation suppresses excessive ROS, balancing antimicrobial defense and inflammation .

Data Interpretation Challenges

Q7: How should I interpret overlapping bands or non-specific signals in Phospho-NCF4 (T154) WB?

• Secondary antibody validation: Test primary antibody with non-relevant secondary (e.g., anti-mouse IgG).

• Phosphate-dependent specificity: Compare lysates from WT vs. T154A-expressing cells .

• Stripping/reprobing: Use anti-GAPDH or anti-β-actin as loading controls.

Example: A band at ~40 kDa in PMA/TPA-treated Jurkat lysates but absent in phosphatase-treated lysates confirms phospho-specificity .

Advanced Methodological Integration

Q8: What advanced techniques can complement Phospho-NCF4 (T154) antibody use in signaling studies?

• Proximity-dependent biotinylation (BioID): Map NCF4 interactomes under phosphorylated vs. non-phosphorylated states.

• Single-molecule localization microscopy (SMLM): Visualize NCF4 localization at membranes vs. inflammasomes.

• CRISPR-Cas9 editing: Generate T154A/K NCF4 knock-in models to study phosphorylation-dependent functions .